128 related articles for article (PubMed ID: 19616898)
1. Comparative immunohistochemical analysis of aurora-A and aurora-B expression in human glioblastomas. Associations with proliferative activity and clinicopathological features.
Samaras V; Stamatelli A; Samaras E; Arnaoutoglou C; Arnaoutoglou M; Stergiou I; Konstantopoulou P; Varsos V; Karameris A; Barbatis C
Pathol Res Pract; 2009; 205(11):765-73. PubMed ID: 19616898
[TBL] [Abstract][Full Text] [Related]
2. No prognostic impact of survivin expression in glioblastoma.
Preusser M; Gelpi E; Matej R; Marosi C; Dieckmann K; Rössler K; Budka H; Hainfellner JA
Acta Neuropathol; 2005 May; 109(5):534-8. PubMed ID: 15843906
[TBL] [Abstract][Full Text] [Related]
3. Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma.
Kurai M; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Suzuki A; Konishi I
Hum Pathol; 2005 Dec; 36(12):1281-8. PubMed ID: 16311121
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of p53 protein expression in glioblastoma.
Birner P; Piribauer M; Fischer I; Gatterbauer B; Marosi C; Ungersböck K; Rössler K; Budka H; Hainfellner JA
Oncol Rep; 2002; 9(4):703-7. PubMed ID: 12066196
[TBL] [Abstract][Full Text] [Related]
5. CD98 immunoreactivity in multinucleated giant cells of glioblastomas: an immunohistochemical double labeling study.
Takeuchi H; Kubota T; Kitai R; Nakagawa T; Hashimoto N
Neuropathology; 2008 Apr; 28(2):127-31. PubMed ID: 18021193
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of c-Met expression in glioblastomas.
Kong DS; Song SY; Kim DH; Joo KM; Yoo JS; Koh JS; Dong SM; Suh YL; Lee JI; Park K; Kim JH; Nam DH
Cancer; 2009 Jan; 115(1):140-8. PubMed ID: 18973197
[TBL] [Abstract][Full Text] [Related]
7. Quantitative investigation of nuclear morphology in glioblastomas and its relation to survival time.
Nafe R; Franz K; Schlote W; Schneider B
Clin Neuropathol; 2003; 22(3):129-36. PubMed ID: 12809355
[TBL] [Abstract][Full Text] [Related]
8. High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas.
Colin C; Voutsinos-Porche B; Nanni I; Fina F; Metellus P; Intagliata D; Baeza N; Bouvier C; Delfino C; Loundou A; Chinot O; Lah T; Kos J; Martin PM; Ouafik L; Figarella-Branger D
Acta Neuropathol; 2009 Dec; 118(6):745-54. PubMed ID: 19774387
[TBL] [Abstract][Full Text] [Related]
9. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
10. Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome.
Zolota V; Tsamandas AC; Aroukatos P; Panagiotopoulos V; Maraziotis T; Poulos C; Scopa CD
Neuropathology; 2008 Feb; 28(1):35-42. PubMed ID: 18181833
[TBL] [Abstract][Full Text] [Related]
11. Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas.
Gunal A; Onguru O; Safali M; Beyzadeoglu M
Neuropathology; 2008 Aug; 28(4):382-6. PubMed ID: 18298442
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme.
Chang CY; Li MC; Liao SL; Huang YL; Shen CC; Pan HC
J Clin Neurosci; 2005 Nov; 12(8):930-3. PubMed ID: 16326273
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 (Cox-2) expression and angiogenesis in glioblastoma.
Onguru O; Gamsizkan M; Ulutin C; Gunhan O
Neuropathology; 2008 Feb; 28(1):29-34. PubMed ID: 18181832
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas.
Szczuraszek K; Mazur G; Jeleń M; Dziegiel P; Surowiak P; Zabel M
Anticancer Res; 2008; 28(2A):1113-8. PubMed ID: 18507062
[TBL] [Abstract][Full Text] [Related]
15. The morphology of perinecrotic tumor cell nuclei in glioblastomas shows a significant relationship with survival time.
Nafe R; Franz K; Schlote W; Schneider B
Oncol Rep; 2006 Sep; 16(3):555-62. PubMed ID: 16865255
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
17. Aurora B expression in post-puberal testicular germ cell tumours.
Esposito F; Libertini S; Franco R; Abagnale A; Marra L; Portella G; Chieffi P
J Cell Physiol; 2009 Nov; 221(2):435-9. PubMed ID: 19626681
[TBL] [Abstract][Full Text] [Related]
18. Expression pattern and clinical prognostic relevance of bone morphogenetic protein-2 in human gliomas.
Liu C; Tian G; Tu Y; Fu J; Lan C; Wu N
Jpn J Clin Oncol; 2009 Oct; 39(10):625-31. PubMed ID: 19797419
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
[TBL] [Abstract][Full Text] [Related]
20. Giant cell glioblastoma is associated with altered aurora b expression and concomitant p53 mutation.
Temme A; Geiger KD; Wiedemuth R; Conseur K; Pietsch T; Felsberg J; Reifenberger G; Tatsuka M; Hagel C; Westphal M; Berger H; Simon M; Weller M; Schackert G
J Neuropathol Exp Neurol; 2010 Jun; 69(6):632-42. PubMed ID: 20467329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
